Scott T. Aaronson | Psychiatrist.com

Original Research

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

Original Research

Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania: A Randomized, 12-Week, Double-Blind Study

Original Research

VNS Improves Quality of Life in Depression

Vagus nerve stimulation (VNS) treatment has been shown to be efficacious in treatment-resistant depression (TRD). Can VNS treatment lead to improvements in quality of life in patients with TRD...

TMS in Anxious Depression

Original Research

TMS in Anxious Depression

Patients with anxious depression tend to have more severe depressive symptoms. This study examined the effects of transcranial magnetic stimulation in these patients.

Long-Term Safety and Efficacy of Zuranolone in MDD

Original Research

Long-Term Safety and Efficacy of Zuranolone in MDD

Most patients with MDD achieved response after 14 days of zuranolone treatment. For patients who responded to their first treatment, the time to repeat treatment was over 4 months.

Pilot Study of High Frequency TMS for Bipolar Depression

Original Research

Pilot Study of High Frequency TMS for Bipolar Depression

In this study of patients with bipolar depression, 87.1% reached response and 74.2% reached remission with 6 weeks of rTMS.

The Long Road Toward Equitable MDMA Treatment in the United States

Commentary

The Long Road Toward Equitable MDMA Treatment in the United States

Kozak and Aaronson discuss challenges in implementation of MDMA-assisted therapy, including insurance and Medicare coverage as well as cultural barriers.